New methodologies to accurately assess circulating active transforming growth factor-β1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices
Keywords: کاردیومیوپاتی دیلاته، کاردیومیوپاتی کامل; CAD; coronary artery disease; CHF; congestive heart failure; DCM; dilated cardiomyopathy; HF; heart failure; LV; left ventricle; LVAD; left ventricular-assist device; PAI-1; plasminogen activator inhibitor-1; SMCA; single-molecule counting assay; TGF-β1;